Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation. (Q40060440)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Li Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Tian-Gui Huang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Marcia Meseck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

John Mandeli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Savio L C Woo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

30 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968355%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

2194-2202

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17968355%20AND%20SRC:MED&resulttype=core&format=json

Anti-tumor immunity induced by interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Role of immature myeloid Gr-1+ cells in the development of antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Combination treatment of murine tumors by adenovirus-mediated local B7/IL12 immunotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Regulatory T cells, tumour immunity and immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Strong-arming immune regulation: suppressing regulatory T-cell function to treat cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Cloning and characterization of GITR ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

New insights into the role of 4-1BB in immune responses: beyond CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): delivery to acute myeloid leukemic blasts using adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021

A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300310

7 January 2021